Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001209191-23-000957

Options or other derivatives

  • General Counsel acquired 123,650 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nickson Philip General Counsel 2023-01-03 Grant or award · Stock Option (Right to Buy) +123,650 123,650 D: show line 1 in the form
Loading xslF345X03/doc4.xml…